By continuous intake of the microalgae Euglena
Confirmed research results suggesting alleviation of symptoms of rheumatoid arthritis

Euglena Co., Ltd.

　Euglena Co., Ltd. (Headquarters: Minato-ku, Tokyo, President: Mitsuru Izumo) has alleviated the symptoms of rheumatoid arthritis by continuously ingesting the powder of the Euglena We are pleased to inform you that we have confirmed the research results that suggest that.

　Rheumatoid arthritis is a type of autoimmune disease in which joints become inflamed due to an overreaction of immunity to their own tissues. This time, mice with rheumatoid arthritis were Euglena powder, paramylon, and food containing amorphous paramylon * 2, and the arthritis score * 3 was measured. As a result, Euglena powder, paramylon and amorphous paramylon had a significantly lower arthritis score than the mice fed with the normal food alone.
　These research results were presented at Euglena Study Group held on November 7, 2015. Going forward, we will continue to carry out research and development with the aim of utilizing the Euglena
　The details are as follows.
　* 1 A polysaccharide in which glucose molecules are linearly polymerized by β-1,3-bonds.
　* 2 Paramylon is chemically treated to break the crystal structure (amorphous).
　* 3 A numerical value that quantitatively expresses the severity of inflamed joints.

Experiments on alleviation of rheumatoid arthritis symptoms

■ Experiment contents
　Collagen was injected subcutaneously to induce rheumatoid arthritis, and mice that developed rheumatoid arthritis Euglena powder, paramylon, and amorphous paramylon every day for a total of 24 days from 2 days after the onset, and only normal food was fed. We compared the arthritis score with the control group). As a result, we confirmed a significant decrease in arthritis score in mice fed food containing Euglena

■ Consideration
　Euglena Continued intake of powder, paramylon and amorphous paramylon may have a relieving effect on rheumatoid arthritis symptoms, suggesting that it may suppress the overreaction of immunity to its own tissues. it was done.

​ ​

-Contact for inquiries from the press-
Euglena Co., Ltd. Public Relations and IR Division